Furthermore, while GATA2-deficient patients have profound monocytopaenia, immunodeficiency and an increased risk of myelodysplasia and acute myeloid leukaemia, none of the patients with WILD in this series had either abnormal monocyte counts or developed myelodysplasia. This evidence concerns the gene GATA2 and Myelodysplasia.